SRGN and neoplasm: Importantly, the expression level of serglycin in the SG-/- tumour tissue was 4.89 ±0.1 (log2), i. e. at background levels, whereas serglycin expression in the SG+/- tumour tissue was 10.52 ±0.4 (log2).